Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Adaptation
100%
During Pregnancy
100%
Antiretroviral Therapy
100%
Pharmacokinetics
100%
HIV-positive Women
100%
Virological Suppression
37%
Improved Outcomes
25%
Drug Exposure
25%
Therapeutic Drug Monitoring
25%
Mother-to-child Transmission
25%
Integrase Strand Transfer Inhibitor (INSTI)
25%
Pharmacokinetic Change
25%
Hepatic Metabolism
12%
Evidence-based
12%
Health Outcomes
12%
Physiological Changes
12%
Transmission Risk
12%
Pharmacogenomics
12%
Plasma Parameters
12%
Pregnancy Disorders
12%
Antiretroviral
12%
Therapeutic Efficacy
12%
Drug Safety
12%
Health Disparities
12%
Protease Inhibitors
12%
International Guidelines
12%
Nucleoside Reverse Transcriptase Inhibitors
12%
Renal Clearance
12%
Lopinavir
12%
Therapy Management
12%
Dolutegravir
12%
Plasma Protein Binding
12%
Subtherapeutic
12%
Dose Adjustment
12%
Cobicistat
12%
HIV in Pregnancy
12%
Long-acting Formulation
12%
Drug Efficacy
12%
Maternal Safety
12%
PMTCT
12%
Renal Changes
12%
Atazanavir
12%
Tailored Approach
12%
Neonatal Safety
12%
Therapy Adjustment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetic
100%
HIV
100%
Therapeutic Drug Monitoring
33%
Pharmacogenomics
16%
Lopinavir
16%
Integrase
16%
Proteinase Inhibitor
16%
Integrase Inhibitor
16%
RNA Directed DNA Polymerase Inhibitor
16%
Cobicistat
16%
Dolutegravir
16%
Atazanavir
16%
Plasma Protein Binding
16%